US Patent Issued to Biontech, Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige on April 22 for "RNA replicon for versatile and efficient gene expression" (German Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,322, issued on April 22, was assigned to Biontech SE (Mainz, Germany) and Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz Gemeinnutzige GmbH (Mainz, Germany).

"RNA replicon for versatile and efficient gene expression" was invented by Tim Beissert (Gross-Gerau, Germany), Ugur Sahin (Mainz, Germany) and Mario Perkovic (Frankfurt, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention embraces a RNA replicon that can be replicated by a replicase of alphavirus origin. The RNA replicon comprises sequence elements required for replication by the replicase, but these sequence elements do not...